Dr. subra kugathasan
Claim this profileEmory University School of Medicine
Studies Crohn's Disease
Studies Ulcerative Colitis
6 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials subra kugathasan is currently running
Mirikizumab
for Ulcerative Colitis
This trial is testing a medication called mirikizumab to see if it can help children with ulcerative colitis or Crohn's disease by reducing inflammation in their digestive tracts.
Recruiting2 awards Phase 33 criteria
Mirikizumab
for Pediatric Crohn's Disease
Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric participants with Crohn's disease. Study periods for the intervention-specific appendix (ISA) will be as follows: * A 12-week induction period * A maintenance period from Week 12 to Week 52, and * A safety follow-up period up to 16 weeks. The study will last about 74 weeks and may include up to 19 visits.
Recruiting2 awards Phase 3
More about subra kugathasan
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments subra kugathasan has experience with
- Mirikizumab
- Hydroxychloroquine
- Mesalamine
- Methotrexate
- Sugar Pill (placebo)
Breakdown of trials subra kugathasan has run
Crohn's Disease
Ulcerative Colitis
Inflammatory Bowel Disease
Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does subra kugathasan specialize in?
subra kugathasan focuses on Crohn's Disease and Ulcerative Colitis. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is subra kugathasan currently recruiting for clinical trials?
Yes, subra kugathasan is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that subra kugathasan has studied deeply?
Yes, subra kugathasan has studied treatments such as Mirikizumab, Hydroxychloroquine, Mesalamine.
What is the best way to schedule an appointment with subra kugathasan?
Apply for one of the trials that subra kugathasan is conducting.
What is the office address of subra kugathasan?
The office of subra kugathasan is located at: Emory University School of Medicine, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.